FDA
Breaking
Macro
Kennedy Health Officials Explored Banning Antidepressants, Threatening Access for 16 Million Americans
Preliminary HHS inquiry into restricting SSRIs signals potential regulatory inflection point for psychiatric drug policy despite administration denials.
AI
Google’s Medical AI Reaches Physician-Level Diagnosis, Forcing Healthcare’s Regulatory Reckoning
AMIE diagnostic system matches clinicians in real-world trials, but deployment hinges on unresolved FDA pathways, liability frameworks, and reimbursement models